Art

J-GLOBAL ID：201602237761901997   Reference number：16A1164449

Research progress in proprotein convertase subtilisin/kexin type 9 monoclonal antibody

前駆蛋白質インベルターゼインベルターゼ9モノクローナル抗体の研究進展【JST・京大機械翻訳】

Author (3)： Sun Yinghao (Key Laboratory of Endocrinology of National Health and Family Planning Commission, Department of Endocrinology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College) ,  Li Naishi (Key Laboratory of Endocrinology of National Health and Family Planning Commission, Department of Endocrinology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College) ,  Zhao Weigang (Key Laboratory of Endocrinology of National Health and Family Planning Commission, Department of Endocrinology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College)
Material： Zhonghua Linchuang Yingyang Zazhi
Volume： 24  Issue： 3  Page： 172-178  Publication year： 2016 
JST Material Number： C3112A  ISSN： 1674-635X  Document type： Article
Article type： 原著論文  Country of issue： China (CHN)  Language： CHINESE (ZH)

Abstract/Point： Proprotein convertase subtilis...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1164449&from=J-GLOBAL&jstjournalNo=C3112A") }}

Thesaurus term： LDL ,  *monoclonal antibody ,  plasma(blood) ,  safety ,  enzyme ,  clinical trial ,  LDL cholesterol ,  Bacillus subtilis ,  receptor ,  *protein
Semi thesaurus term： 心血管リスク ,  臨床研究 ,  臨床応用 ,  阻害剤 ,  血中脂質 , 【Automatic Indexing@JST】

Author keywords (6)： Proprotein convertase subtilisin/kexin type 9 ,  Monoclonal antibody ,  Dyslipidemia ,  Evolocumab ,  Alirocumab ,  Bococizumab

JST classification (1)： Metabolic diseases,nutritional diseases in general.  (GD05010J)

Terms in the title (4)： 蛋白質 ,  モノクローナル抗体 ,  研究 ,  進展